The targeted next-generation sequencing revealed a stop-gain variant mutation p.R257X (c.769C > T) in homozygous status in the AIRE gene on chromosome 21q22.3, highly suggestive of autoimmune polyendocrine syndrome type 1 (APS-1). The gene discussed is AIRE; the disease is Autoimmune polyendocrinopathy type 1.